SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Apr-24 8:59 PM View: | Metagenomi, Inc. (MGX) | 01-Apr-24 | Grant | 69,316 | -- | -- | 100% 0 to 69.32K | |
05-Apr-23 4:27 PM View: | Century Therapeutics, Inc. (IPSC) | 03-Apr-23 | Option Exercise | 7,452 | $1.03 | $7,675.56 | 3% 249.08K to 256.54K | |
23-Mar-23 7:31 PM View: | Century Therapeutics, Inc. (IPSC) | 23-Mar-23 | Option Exercise | 220,930 | $1.03 | $227,558.00 | 505% 43.75K to 264.68K | |
23-Mar-23 7:31 PM View: | Century Therapeutics, Inc. (IPSC) | 23-Mar-23 | Option Sale | 15,597 | $3.55 | $55,369.30 | (6%) 264.68K to 249.08K | |
23-Mar-23 7:31 PM View: | Century Therapeutics, Inc. (IPSC) | 22-Mar-23 | Option Exercise | 65,698 | $1.03 | $67,668.90 | 150% 43.75K to 109.45K | |
23-Mar-23 7:31 PM View: | Century Therapeutics, Inc. (IPSC) | 22-Mar-23 | Option Sale | 65,698 | $3.72 | $244,640.00 | (60%) 109.45K to 43.75K | |
23-Mar-23 7:31 PM View: | Century Therapeutics, Inc. (IPSC) | 21-Mar-23 | Option Exercise | 63,616 | $1.03 | $65,524.50 | 145% 43.75K to 107.37K | |
23-Mar-23 7:31 PM View: | Century Therapeutics, Inc. (IPSC) | 21-Mar-23 | Option Sale | 63,616 | $3.77 | $239,870.00 | (59%) 107.37K to 43.75K | |
06-Feb-23 6:50 PM View: | Century Therapeutics, Inc. (IPSC) | 02-Feb-23 | Grant | 43,750 | -- | -- | 100% 0 to 43.75K | |
03-Mar-17 1:29 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Mar-17 | Payment of Exercise | 18,084 | $44.77 | $809,621.00 | (22%) 82.97K to 64.89K | 15% |
09-Feb-17 7:23 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 07-Feb-17 | Grant | 12,656 | -- | -- | 18% 70.32K to 82.97K | |
05-Jan-17 2:20 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 03-Jan-17 | Payment of Exercise | 1,306 | $48.60 | $63,471.60 | (2%) 71.62K to 70.32K | 22% |
12-Sep-16 8:25 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 08-Sep-16 | Grant | 5,000 | -- | -- | 8% 66.62K to 71.62K |